Cargando...
(18)F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma
We described the clinical impact of (18)F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma. We detailed the diagnostic imaging workup focusing our attention on the CT, MR, and (18)F-FDG PET/MR different findings. In this case, (18)...
Gardado en:
| Publicado en: | Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6694445/ https://ncbi.nlm.nih.gov/pubmed/31456863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-019-00597-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|